Digital platforms and artificial intelligence: view from EULAR 2026
From the article
Artificial intelligence and digital health platforms have the potential to support patient education, shared decision-making and engagement across rheumatic and musculoskeletal diseases, as research presented at the European Alliance of Associations for Rheumatology Congress 2026 highlights. Health literacy remains a key determinant of outcomes in rheumatic and musculoskeletal diseases (RMDs), yet many patients continue to […] The post Digital platforms and artificial intelligence: view from EULAR 2026 appeared first on Hospital Healthcare Europe .
Continue reading on hospitalhealthcare.comYou might also wanna read
Generalisability of proposed clinical sepsis phenotypes questioned by international validation study
hospitalhealthcare.com·1d ago
Nirsevimab linked to marked reduction in paediatric RSV hospitalisations, real-world study shows
hospitalhealthcare.com·2d ago
Evidence linking legume and soy intake with reduced hypertension risk strengthens
hospitalhealthcare.com·2d ago
Delgocitinib cream linked to low systemic exposure in chronic hand eczema, post hoc analysis shows
hospitalhealthcare.com·5d ago
Shaping the future of cardio-oncology: insights from ESC Cardio-Oncology 2026 and beyond
hospitalhealthcare.com·5d ago
Respiratory oscillometry shows considerable potential for infant lung assessment
hospitalhealthcare.com·6d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.